DrugPatentWatch Database Preview

Biogen Idec Company Profile

« Back to Dashboard

What is the competitive landscape for BIOGEN IDEC, and what generic alternatives to BIOGEN IDEC drugs are available?

BIOGEN IDEC has two approved drugs.

There are fifteen US patents protecting BIOGEN IDEC drugs.

There are five hundred and ninety-eight patent family members on BIOGEN IDEC drugs in thirty-eight countries and twenty-nine supplementary protection certificates in eleven countries.

Summary for Biogen Idec

International Patents:	598
US Patents:	15
Tradenames:	2
Ingredients:	2
NDAs:	2
Patent Litigation for Biogen Idec:	See patent lawsuits for Biogen Idec

Drugs and US Patents for Biogen Idec

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Biogen Idec Inc	TECFIDERA	dimethyl fumarate	CAPSULE, DELAYED RELEASE;ORAL	204063-002	Mar 27, 2013		RX	Yes	Yes	7,320,999
Biogen Idec Inc	TECFIDERA	dimethyl fumarate	CAPSULE, DELAYED RELEASE;ORAL	204063-001	Mar 27, 2013		RX	Yes	No	7,803,840
Biogen Idec	SPINRAZA	nusinersen sodium	SOLUTION;INTRATHECAL	209531-001	Dec 23, 2016		RX	Yes	Yes	8,110,560
Biogen Idec	SPINRAZA	nusinersen sodium	SOLUTION;INTRATHECAL	209531-001	Dec 23, 2016		RX	Yes	Yes	6,210,892
Biogen Idec Inc	TECFIDERA	dimethyl fumarate	CAPSULE, DELAYED RELEASE;ORAL	204063-002	Mar 27, 2013		RX	Yes	Yes	8,759,393		Y

Expired US Patents for Biogen Idec

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Biogen Idec Inc	TECFIDERA	dimethyl fumarate	CAPSULE, DELAYED RELEASE;ORAL	204063-001	Mar 27, 2013	8,759,393
Biogen Idec	SPINRAZA	nusinersen sodium	SOLUTION;INTRATHECAL	209531-001	Dec 23, 2016	6,166,197
Biogen Idec Inc	TECFIDERA	dimethyl fumarate	CAPSULE, DELAYED RELEASE;ORAL	204063-002	Mar 27, 2013	8,524,773
Biogen Idec	SPINRAZA	nusinersen sodium	SOLUTION;INTRATHECAL	209531-001	Dec 23, 2016	6,210,892
Biogen Idec Inc	TECFIDERA	dimethyl fumarate	CAPSULE, DELAYED RELEASE;ORAL	204063-001	Mar 27, 2013	8,524,773

Paragraph IV (Patent) Challenges for BIOGEN IDEC drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
	Delayed-releaseCapsules	120 mg and 240 mg		2017-03-27

International Patents for Biogen Idec Drugs

Country	Patent Number	Estimated Expiration
Germany	69232032
European Patent Office	0975654
Ireland	921850
Japan	3553068
European Patent Office	1080225

Supplementary Protection Certificates for Biogen Idec Drugs

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
2548560	C20170038 00228	Estonia		PRODUCT NAME: NUSINERSEEN;REG NO/DATE: EU/1/17/1188 01.06.2017
2137537	1490038-5	Sweden		PRODUCT NAME: DIMETHYL FUMARATE; REG. NO/DATE: EU/1/13/837 20140203
2137537	PA2014024	Lithuania		PRODUCT NAME: DIMETHYLIS FUMARAS; REGISTRATION NO/DATE: EU/1/13/837/001-002 20140130
1910395	300905	Netherlands		PRODUCT NAME: NUSINERSEN, DESGEWENST IN DE VORM VAN EEN ZOUT; REGISTRATION NO/DATE: EU/1/17/1188 20170601
2137537	CA 2014 00035	Denmark		PRODUCT NAME: DIMETHYL FUMARAT (DIMETHYLFUMARAT); REG. NO/DATE: EU/1/13/837/001-002 20140130

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Biogen Idec
• Biogen Idec Inc
• Bioglan